Alvin Shih - Net Worth and Insider Trading
Alvin Shih Net Worth
The estimated net worth of Alvin Shih is at least $2 Million dollars as of 2024-09-20. Alvin Shih is the EVP of Research & Development of Travere Therapeutics Inc and owns about 158,334 shares of Travere Therapeutics Inc (TVTX) stock worth over $2 Million. Details can be seen in Alvin Shih's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alvin Shih has not made any transactions after 2016-09-01 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Alvin Shih
Alvin Shih Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alvin Shih owns 1 companies in total, including Travere Therapeutics Inc (TVTX) .
Click here to see the complete history of Alvin Shih’s form 4 insider trades.
Insider Ownership Summary of Alvin Shih
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TVTX | Travere Therapeutics Inc | 2016-09-01 | EVP of Research & Development |
Alvin Shih Latest Holdings Summary
Alvin Shih currently owns a total of 1 stock. Alvin Shih owns 158,334 shares of Travere Therapeutics Inc (TVTX) as of September 1, 2016, with a value of $2 Million.
Latest Holdings of Alvin Shih
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TVTX | Travere Therapeutics Inc | 2016-09-01 | 158,334 | 15.07 | 2,386,093 |
Holding Weightings of Alvin Shih
Alvin Shih Form 4 Trading Tracker
According to the SEC Form 4 filings, Alvin Shih has made a total of 0 transactions in Travere Therapeutics Inc (TVTX) over the past 5 years. The most-recent trade in Travere Therapeutics Inc is the sale of 8,750 shares on September 1, 2016, which brought Alvin Shih around $142,100.
Insider Trading History of Alvin Shih
- 1
Alvin Shih Trading Performance
Alvin Shih Ownership Network
Alvin Shih Owned Company Details
What does Travere Therapeutics Inc do?
Who are the key executives at Travere Therapeutics Inc?
Alvin Shih is the EVP of Research & Development of Travere Therapeutics Inc. Other key executives at Travere Therapeutics Inc include Chief Medical Officer Jula Inrig , Senior Vice President & R&D William E. Rote , and Chief Financial Officer Christopher R. Cline .
Travere Therapeutics Inc (TVTX) Insider Trades Summary
Over the past 18 months, Alvin Shih made no insider transaction in Travere Therapeutics Inc (TVTX). Other recent insider transactions involving Travere Therapeutics Inc (TVTX) include a net sale of 4,870 shares made by Christopher R. Cline , a net sale of 9,089 shares made by William E. Rote , and a net sale of 9,089 shares made by Elizabeth E Reed .
In summary, during the past 3 months, insiders sold 37,969 shares of Travere Therapeutics Inc (TVTX) in total and bought 0 shares, with a net sale of 37,969 shares. During the past 18 months, 70,194 shares of Travere Therapeutics Inc (TVTX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 70,194 shares.
Travere Therapeutics Inc (TVTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Travere Therapeutics Inc Insider Transactions
Alvin Shih Mailing Address
Above is the net worth, insider trading, and ownership report for Alvin Shih. You might contact Alvin Shih via mailing address: C/o Retrophin, Inc., 777 Third Avenue, 2, New York Ny 10017.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
